Autoimmune Pulmonary Alveolar Proteinosis
📧 Sign up to get email alerts when something new happens for Autoimmune Pulmonary Alveolar Proteinosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). [Phase 3]
A Phase 3 clinical trial update reports that inhaled molgramostim is being studied in pediatric participants with autoimmune pulmonary alveo…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Molgramostim Nebulizer Solution Expanded Access Program Protocol
This document provides an updated protocol for Savara's Expanded Access Program offering molgramostim nebulizer solution to patients with Au…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) [Phase 3]
Phase 3 trial of inhaled molgramostim for autoimmune pulmonary alveolar proteinosis has posted results and the study remains active but not …
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Study of Human Bone Marrow Mesenchymal Stem Cells in APAP [Phase 2]
A Phase 2 clinical trial evaluating human bone marrow mesenchymal stem cells for autoimmune pulmonary alveolar proteinosis is currently acti…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis [Phase 3]
Phase 3 safety-extension trial of inhaled molgramostim for autoimmune pulmonary alveolar proteinosis was terminated; results were posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Inhaled GM-CSF Therapy of Autoimmune PAP [Phase 2]
Phase 2 trial assessing inhaled GM-CSF therapy for autoimmune pulmonary alveolar proteinosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis [Phase 2]
Phase 2 trial update on inhaled molgramostim (rhGM-CSF) for autoimmune pulmonary alveolar proteinosis reports efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP) [Phase 2]
A Phase 2 clinical trial is evaluating inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) for autoimmune pulmonary alveolar p…